Mukka Proteins Overseas Subsidiary Starts Commercial Production In Oman

Market snapshot: Mukka Proteins Limited has announced that its overseas subsidiary, United Gulf Fishery Products LLC, has officially commenced commercial production of fish meal and fish oil in Oman. Mukka Proteins holds a 68% controlling stake in the Oman-based unit, which was acquired to strengthen its international manufacturing footprint. This operational milestone marks a key step in expanding the company's global supply capabilities and enhancing production stability.

Data Snapshot

• Mukka Proteins holds a 68% controlling stake in United Gulf Fishery Products LLC, acquired for OMR 34,000 (equivalent to ₹79.56 lakh) in December 2025.
• Mukka Proteins' standalone revenue for Q1FY27 grew by 187% YoY to ₹490 crore, driven by a 49% YoY increase in sales volume.
• Consolidated inventory levels decreased by 7% to ₹800 crore as on August 30, 2026, compared to ₹867 crore as on March 31, 2026.

What's Changed

• The Oman manufacturing unit has transitioned from project setup stage to active commercial production.
• Mukka Proteins' credit outlook was revised to Stable from Negative on October 7, 2026, reflecting a significant improvement in operating performance and liquidity.

Key Takeaways

• Operations have commenced at the Oman subsidiary, United Gulf Fishery Products LLC, expanding the group's global footprint.
• The setup mitigates seasonal sourcing limits in India, where raw fish availability dictates manufacturing output and raw material costs represent over 80% of sales.
• Revenue momentum is robust, with a 187% YoY increase in standalone revenue in Q1FY27 and credit rating outlook revised to Stable.

SAHI Perspective

The operationalization of the Shinas facility in Oman represents a significant structural hedge for Mukka Proteins. Sourcing raw materials from active Middle Eastern fishing zones allows the company to operate year-round, bypassing the traditional monsoon fishing bans and seasonal supply shocks in India. This move, combined with a recent Stable credit outlook and capital infusion from a ₹47 crore equity warrant issue, enhances the company's capability to process and liquidate its inventory efficiently.

Market Implications

With exports traditionally comprising a vital portion of the revenue mix, establishing international processing bases improves global supply chain efficiency. Stable production from Oman facilitates smoother deliveries to major import destinations such as China, South Korea, and Taiwan, thereby improving operating cycles and easing high inventory-holding pressures.

Trading Signals

Market Bias: Bullish

Commercial production in Oman opens a stable sourcing corridor, mitigating India's seasonal catch volatility. Combined with the recent credit outlook upgrade to Stable and a stellar 187% YoY standalone revenue growth to ₹490 crore in Q1FY27, the long-term fundamentals look highly supportive.

Overweight: Aquaculture Feed Ingredients, Marine Proteins, Animal Nutrition

Trigger Factors:

• Sustained quarterly revenues and operating margins above 9% in FY27.
• Further liquidation of consolidated inventory below the ₹800 crore level.
• Receipt of the remaining ₹35.25 crore from the convertible warrants issue by March 2028.

Time Horizon: Medium-term (3-12 months)

Industry Context

The global fish meal and fish oil industry is heavily influenced by strict catch quotas and climate patterns. Key global exporters like Peru and Chile have experienced severe supply disruptions due to environmental regulations. For Indian players, possessing diversified geographic footprints across India and Oman provides a competitive advantage in securing raw pelagic fish and ensuring consistent feed exports.

Key Risks to Watch

• Exposure to volatile raw fish prices, given that raw material expenses constitute over 80% of sales.
• Elongated working capital cycles resulting from high inventory-holding periods.
• Foreign exchange fluctuations from extensive international trade and overseas investments.

Recent Developments

On October 7, 2026, CareEdge Ratings reaffirmed Mukka Proteins' ratings and upgraded the outlook to Stable from Negative on the back of rising global prices and ₹490 crore standalone revenue in Q1FY27. On September 1, 2026, the company announced its Bengaluru organic waste-to-value bioconversion roadmap, currently handling 200 TPD of wet waste with plans to scale up to 1,000 TPD by December 2027.

Closing Insight

Mukka Proteins' successful operational launch in Oman positions it to capture high-margin export demand while hedging against localized supply shocks. Supported by improved credit stability, this operational milestone is a key catalyst for structural expansion.

High Performance Trading with SAHI.